Forian IncNASDAQ:FORA
- LAST PRICE2.7201
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.3500/ 1
- Ask / Lots2.7200/ 3
- Open / Previous Close0.0000 / 2.7201
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FORA |
|---|---|---|
| 09:48 ET | 494 | 2.85 |
| 09:50 ET | 3546 | 2.84 |
| 10:17 ET | 166 | 2.73 |
| 11:13 ET | 100 | 2.7065 |
| 11:51 ET | 200 | 2.71 |
| 12:50 ET | 700 | 2.72 |
| 12:52 ET | 1700 | 2.72 |
| 01:24 ET | 219 | 2.72 |
| 01:26 ET | 956 | 2.72 |
| 01:33 ET | 1966 | 2.7082 |
| 01:48 ET | 750 | 2.86 |
| 02:11 ET | 100 | 2.72 |
| 02:42 ET | 3446 | 2.7201 |
Apr 14, 2024
Forian Inc. Announces the Passing of Director Martin J. Wygod, from 6:03PM ET on Sunday Apr 14, 2024 by Dow Jones
6:03PM ET on Sunday Apr 14, 2024 by Dow JonesPress Release: Forian Inc. Announces the Passing of Director Martin J. Wygod, from 6:03PM ET on Sunday Apr 14, 2024 by Dow Jones
6:03PM ET on Sunday Apr 14, 2024 by Dow Jones
Apr 4, 2024
DJ Forian Price Target Maintained With a $5.00/Share by Roth MKM, from 10:12AM ET on Thursday Apr 04, 2024 by Dow Jones
10:12AM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Forian Inc | 84.7M | 68.4x | --- |
Marti Technologies Inc | 86.0M | -2.2x | --- |
YY Group Holding Ltd | 115.9M | 440.8x | --- |
Intellicheck Inc | 61.9M | -30.7x | --- |
Aware Inc | 36.1M | -4.9x | --- |
HeartCore Enterprises Inc | 19.2M | -4.8x | --- |
Company Information
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. The Company’s operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries.
Contact Information
- Headquarters
- 41 University Drive, Suite 400NEWTOWN, PA, United States 18940
- Phone
- 267-757-8707
- Fax
- 302-636-5454
Executives
- Executive Chairman of the Board, President, Chief Executive Officer
- Max Wygod
- Chief Financial Officer
- Michael Vesey
- Executive Vice President, General Counsel, Secretary
- Edward Spaniel
- Chief Strategy Officer, Director
- Adam Dublin
- Director
- Martin Wygod
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $84.7M |
|---|---|
Revenue (TTM) | $20.5M |
Shares Outstanding | 31.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.08 |
EPS | $0.04 |
Book Value | $0.85 |
P/E Ratio | 68.4x |
Price/Sales (TTM) | 4.1 |
Price/Cash Flow (TTM) | 46.8x |
Operating Margin | -26.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
